Jerry Cavallerano O.D., Ph.D.

​Dr. Cavallerano's research is conducted predominantly through the Beetham Eye Institute's (BEI) participation in the National Eye Institute's Diabetic Retinopathy Clinical Research Network ( In the, Dr. Cavallerano is a certified refractionist and visual acuity examiner. Additionally, he provides initial refraction certification for all refractionists in the, which presently has more than 200 active sites nationwide. Additionally, Dr. Cavallerano provides image grading services for ultrawide field retinal images as part of the Reading Center at the BEI for the Protocol AA clinical trial. Dr. Cavallerano also participates in other clinical trials at the Beetham Eye Institute, including trials with the Dana Farber Cancer Institute and Joslin's 50 Year Medalist Study, and he continues to provide visual function support to the ongoing National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-sponsored Epidemiology of Diabetes Interventions and Complications Trial (EDIC), the observational continuation study of the Diabetes Control and Complications Trial. Additional research involves the use of the Joslin Vision Network, the telemedicine program of the Beetham Eye Institute and the Joslin Diabetes Center. In line with Joslin's telemedicine initiatives, he has actively pursued rigorous scientific validation studies of novel state-of-the-art retinal imaging devices. These studies have adhered to standardized protocols that ensure data integrity. Recent validation studies have included automated 7 field retinal imaging, low light nonmydriatic fundus cameras and ultrawide field scanning laser ophthalmoscopes, and assessment of clinical outcomes and population characteristics at sites where the Joslin Vision Network telemedicine program contributes to patient care. Ongoing studies are assessing the impact of peripheral retinal lesions on the progression of diabetic retinopathy.


​Office Phone Number: 1-617-309-4283